Professional Documents
Culture Documents
Drugs For Psychiatric Disorders
Drugs For Psychiatric Disorders
DISORDERS
Dr Qodriyah Hj Mohd Saad Dept of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia qodryrz@ymail.com
PSYCHOSIS
Variety Sx:
mental disorder
of perception (delusion & hallucination) grossly disorganized behavior & speech capacity to recognize reality causes functional organic
distortion
DRUGS M ETABOLIC
TRAUMA
Axis I: major mental disorders schizophrenia, bipolar d/o, depression, anxiety d/o, ADHD Axis II: underlying pervasive or personality conditions, developmental disorders, learning disabilities, mental retardation
SCHIZOPHRENIA
positive
Sx (distort function)
Sx (diminished function)
3.
4.
DOPAMINERGIC SYSTEMS
1.
2. 3.
4.
5.
Mesolimbic-mesocortical : emotion & behavior Nigrostriatal : motor coordination Hypothalamo-hypophyseal/ Tuberoinfundibular : regulation of prolactin secretion Medullary-periventricular : eating habit Incertohypothalamic ?
ANTIPSYCHOTIC AGENTS
Typical/Classic
1. Phenothiazines
2. Thioxanthenes
3. Butyrophenones
Olanzapine
Typical/Classic
1.Phenothiazines Derivatives
i. Aliphatic : Chlorpromazine
ii. Piperidine : Thioridazine
iii.
Piperazine : Fluphenazine
PHARMACOKINETICS
Oral, rectal, i/m, i/v, depot injection (fluphenazine, haloperidol, clozapine, risperidone, olanzapine)
lipid soluble
protein bound
metabolism : liver active metabolite 1st pass metabolism excretion: urine, feces
t 1/2 = 10 -24 h
MECHANISM OF ACTION
Complex,
dopamine receptor subtype selectively Antipsychotic effect : X D2 > D1 (after 2 - 3 wks) muscarinic X 1 adrenoceptor X 5-HT2 X histamine
side effects
PHARMACOLOGIC EFFECTS
1. CNS
Antipsychotic - X mesolimbic-mesocortical - agitation - emotional quieting - paranoid idea block D2 - hallucination - anxiety
3.
ADVERSE REACTIONS
1.
i.
Neurological effects
Extrapyramidal - X Nigrostriatal
(antimuscarinic)
- akathisia
- dystonia
Rx:diphenhydramine
(sedative antihistamine & anticholinergic)
dyskinesia - occur late (months/years) - involuntary facial & limb movement - Causes: ? supersensitivity DA receptor ? dysfunction GABAergic neuron - Rx : stop antipsychotic/ Clozapine/Olanzapine Seizure : with CPZ, clozapine
iii.
- dry mouth
- blurred vision - constipation
- urinary retention
Metabolic & endocrine - X Tuberoinfundibular (inhibit PIH hyperprolactinemia) - weight gain - amenorrhoea-galactorrhoea - impotence - infertility - gynaecomastia
anti adrenergic
thioridazine
5.
Ocular complication - lens & cornea deposit ( CPZ) - retinal deposit resemble retinitis pigmentosa (thioridazine)
Allergic reaction
BIPOLAR
BIPOLAR
Past/present history of manic episode + depression Elevated, expansive or irritable mood Inflated self-esteem (grandiose) need for sleep without feeling fatigue >>talkative Racing thoughts Easily distracted physical activity Negative outcomes (gambling, accidents)
MANIA
Cause:
?
MOOD STABILIZER
Aim:
Stabilizes
Prevent
Drugs
kation (Li+)
absorbed orally
Excretion:
therapeutic index - monitor [Li+] blood, tears, saliva Li+ several days & 2 4 weeks to fully develop
Effects
+ - MECHANISM Li
OF ACTION
Possible mechanism: 1. Li+ replaces Na+ - equally distributed in/out cell affect ion flux across brain cell/ modify cellular membrane property 2. Li+ X release NA & DA in CNS
3. Li+ X enzyme involve in recycling of membrane phosphoinositide 2nd messenger adrenergic & muscarinic transmission (refer Katzung 10th ed. Pg 470)
1. CNS - tremor, ataxia, choreoathetosis, - slurred speech/aphasia - mental confusion, forgetfulness, drowsiness - motor hyperactivity
2. Thyroid dysfunction - goitre (interfere tyrosine iodination but normally pt. euthyroid) - hypothyroidism
3. Kidney
4. Electrolyte - initial Na+ & H20 loss Na+ & H20 retention oedema (due to aldosterone secretion) 5. CVS - benign & reversible inversion T wave (C/I in pt. with sick sinus syndrome)
- rash
Pregnancy fetal congenital abnormalities (cardiac Ebsteins anomaly) fetal goitre, hypotonia
Breastfeeding secreted in milk - baby lethargic, cyanose, abnormal Moro reflex
DRUG INTERACTIONS
Li+ clearance - thiazide diuretics - ACE inhibitors - tetracyclines - NSAIDs (except aspirin & acetaminophen) Li+ toxicities All antipsychotics (except clozapine & newer drugs) + Li+ extrapyramidal Sx
CARBAMAZEPINE
Alternative to Li+
Action: ? sensitization of brain to repeated episode of mood swing Indication : acute mania mania prophylaxis - produce stability in rapid cycling patient - pt who are refractory/intolerant to Li+ - > sedating than Li+
Used alone or + Li+
ANTIDEPRESSANT
DEPRESSION
Depression
is a mood disorder affecting psychomotor functions Energy, sleep, appetite, libido, ability to do activity feeling of sadness, hopelessness, despair, no interest to do daily activities
Intense
Types of depression
1. REACTIVE - most common
20 to trauma spontaneous recovery
2. ENDOGENOUS
inability to cope with ordinary life events cause not obvious - genetic 3. BIPOLAR DISORDER depressive d/o + alternate with mania
PATHOGENESIS OF DEPRESSION
Amine Hypothesis:
depression is due to deficiency/decrease of monoamines such as serotonin and noradrenaline in the brain
Post mortem study did not show significant decreased in NE & 5HT in depressive patients 2nd generation antidepressant (Bupropion) has little effect on NE & 5HT and yet has antidepressant effect Changes in brain amine activity is immediate however, the antidepressant effect only seen after 2-3 weeks
Antidepressants - Classification:
1.Tricyclic / Polycyclic Antidepressants (TCA) Prototype imipramine, amitriptyline Second generation amoxapine, maprotiline, bupropion 2. Selective Serotonin Reuptake Inhibitors (SSRIs) fluoxetine paroxetine sertraline 3. Monoamine Oxidase Inhibitors (MAOIs) phenelzine tranylcypromine
Inhibits amine pump Therefore it block the reuptake of monoamine NE/5HT Increase amines at presynaps (immediate)
TCA - Pharmacokinetic
Metabolism:
liver Demethylation, aromatic hydroxylation & glucuronide conjugation Amitriptyline Nortriptyline Imipramine Desipramine
Excretion:Kidney
Onset of action is late about 2-3 weeks In depressed patient - Elevated mood, improved mental alertness, improved physical activities No effect on normal person
CVS
tachycardia arrhythmias postural
E.g.
CNS
depressants sedation
Antipsychotics
seizure
dry mouth
Antimuscarinics
2.
3.
Imipramine bedwetting
Panic disorder
Less A/E than tricyclic antidepressants (TCA) Less likely to induce mania
SSRI - Pharmacokinetic
Orally given with constant dose fluoxetine actively demethylated active metabolite (norfluoxetine) Slowly excreted fluoxetine T = 1-10 days norfluoxetine T = 3-30 days
Anxiety Insomnia
Anorexia
GIT symptoms
Weight loss
Sexual dysfunction, libido
Teratogenic (paroxetine)
Overdose - seizure
2.
Antidepressants
Panic disorder
3.
4. 5. 6.
Obsessive compulsive
Bulimia nervosa Anorexia nervosa
Premenstrual syndrome
Phenelzine
Tranylcypromine
MAOIs - Pharmacokinetic
MAOIs: interactions
1. Tyramine-enriched food cheese reaction severe hypertension (throbbing headache, +/intracranial haemorrhage)
2. Indirectly-acting sympathomimetic amines (eg. adrenaline, amphetamines) hypertensive crisis
Orthostatic
Blurred Dry
hypotension
vision
mouth
Weight
gain
allergic/unresposive to tricyclic
antidepressant.
Patients
Treatment Atypical